REQUEST A DEMO
Total
USD $0.00
Search more companies

Droguerias Fami Pharma S.A.S (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Droguerias Fami Pharma S.A.S Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Droguerias Fami Pharma S.A.S is an enterprise based in Colombia. Its main office is in Bogota D.C.. The company operates in the Pharmacies and Drug Stores sector. It was first established on July 22, 2019. It currently has a total number of 31 (2024) employees. There was a net sales revenue increase of 5.94% reported in Droguerias Fami Pharma S.A.S’s latest financial highlights for 2023. There was a total negative growth of 31.1% in Droguerias Fami Pharma S.A.S’s total assets over the same period. In 2023, Droguerias Fami Pharma S.A.S’s net profit margin increased by 0.24%.

Headquarters
Calle 70 C 58 25
Bogota D.C.; Bogota D.C; Postal Code: 0223

Contact Details: Purchase the Droguerias Fami Pharma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Droguerias Fami Pharma S.A.S report to view the information.
Outstanding Shares:
Purchase the Droguerias Fami Pharma S.A.S report to view the information.
Incorporation Date:
July 22, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Droguerias Fami Pharma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
5.94%
Total operating revenue
5.94%
Operating profit (EBIT)
95.34%
Net Profit (Loss) for the Period
30.69%
Total assets
-31.1%
Total equity
44.41%
Operating Profit Margin (ROS)
0.86%
Net Profit Margin
0.24%
Return on Equity (ROE)
-3.23%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?